fda compounding semaglutide warning letters september 2025 A company called Nomida has received an letter for offering for sale injectable weight-loss treatments. None of their offerings are FDA-approved. Nomida is allegedly selling unapproved and Tirzepatide "kits" Why the FDA Issued 30

The service at Serotonin is outstandingeveryone is friendly, welcoming, and always hustling to provide the best experience

Personalized medicine approaches may eventually match individual patients to optimal compounds based on genetic, metabolic, or other biomarkers

Notably, the patient also alleged the physician violated Arizonas consumer fraud statute by failing to warn her about mesh products dangers and lack of efficacy

PlexusDx partners with pharmacies that use insulated packaging with temperature-monitoring data loggers to ensure semaglutide never exceeds safe temperature limits during transit

Gaspari et al

However, persistent or distressing changes should be discussed with a healthcare provider